The metabolic and clinical responses to intravenously administered atropine
+ meperidine (pethidine), glycopyrrolate + meperidine, diazepam and placeb
o were examined in 76 healthy children. After atropine + meperidine and gly
copyrrolate + meperidine administration, a significant antisialogogue effec
t, tachycardia and elevation in systolic blood pressure were observed. Diaz
epam decreased oxygen consumption (VO2) whereas atropine + meperidine incre
ased both VO2 and energy expenditure (EE). The maximal effect of diazepam o
n VO2 was found 10 min after drug administration (mean difference from base
line -10.0%) and maximal effect of atropine + meperidine on VO2 and EE afte
r 5 min (mean difference from baseline +6.0% and +3.3%, respectively). It i
s concluded that intravenous administration of meperidine with atropine or
glycopyrrolate is followed by profound anticholinergic effects and such com
binations do not appear to be suitable for clinical purposes. Although stat
istically significant, the alterations in VO2 and EE after diazepam and atr
opine + meperidine premedication can be considered clinically insignificant
because they were of short duration and the measured changes represented o
nly a fraction of fluctuation seen in normal values.